SCHEMBL28853302

SCHEMBL28853302

CNCC(O)(c1ccccc1)c1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.52
ESR2 Q92731 5/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 2/20 0.52
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
SMN1; SMN2 Q16637 6/20 0.43
HTT P42858 4/20 0.43
LMNA P02545 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
POLB P06746 1/20 0.43
XBP1 P17861 1/20 0.43
MAPK1 P28482 1/20 0.43
KIF11 P52732 1/20 0.41
TYR P14679 1/20 0.39
AR P10275 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5035455 0.90 MEN1 (0.53) ALDH1A1MEN1KMT2ASMN1; SMN2HTT
SCHEMBL10598204 0.79 ESR1 (0.57) ESR1ESR2ALDH1A1CYP3A4MEN1
Bromide SCHEMBL28654848 0.76 ESR1 (0.45) ESR1ESR2ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL13539406 0.75 NPSR1 (0.67) CYP3A4MEN1KMT2ASMN1; SMN2HTT
SCHEMBL28325123 0.75 NPSR1 (0.43) ALDH1A1CYP3A4MEN1KMT2ASMN1; SMN2
SCHEMBL10156588 0.74 CYP2C19 (0.50) ALDH1A1CYP3A4MEN1KMT2ASMN1; SMN2
SCHEMBL3444934 0.74 KCNN4 (0.44) ALDH1A1CYP3A4MEN1KMT2ASMN1; SMN2
SCHEMBL12305719 0.74 SHBG (0.59) ESR1ESR2ALDH1A1CYP3A4MEN1
SCHEMBL7411903 0.73 CACNA1B (0.60) ESR1ESR2ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL6814948 0.72 ESR1 (0.59) ESR1ESR2ALDH1A1CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107405337-A Substituted chroman and application method 艾伯维公司 2017-11-28 CN disclosed